Protalix BioTherapeutics PLX
NYSE PLX
$2.57 -0.07 (-2.65%)
As of: Oct 21, 2026 · 3:59 PM EDT

Protalix BioTherapeutics (PLX) Long-Term Investments (2020)

Updated

Protalix BioTherapeutics' Long-Term Investments came in at $5.03 million for Q2 2020, down 59.8% from the prior quarter.

Analysis

Protalix BioTherapeutics (PLX) Long-Term Investments (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 266.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 297.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 1.56 Bn
10 Protalix BioTherapeutics 207.16 Mn 55.78 Mn 12.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 5.03 Mn
Mar 31, 2020 12.51 Mn
API Access

Protalix BioTherapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=PLX&period=max&api_key=YOUR_API_KEY